SOLACI-CACI 2021 | PICS-AICS Session

✔️ Watch the PICS-AICS session in the SOLACI-CACI 2021 Congress.

👨‍🏫 Program:

  • 02:07 – Initial Experience with Myvalve in Pulmonary Position – Carlos Pedra
  • 17:54 – Mid-Term Follow-Up of Patients with Venus P Valve in LATAM – Francisco Garay
  • 32:24 – New Insights in Tricuspid Valve Replacement – Raúl Arrieta
  • 45:49 – Early Results with Pulsta Valve Replacement in Argentina – Alejandro Peirone
  • 01:00:37 – What is the Limit for Edward Sapien Valve Implantation? – Ahmet Çelebi

👉🏻 Moderators: Ziyad Hijazi & Damien Kenny
👉🏻 Panelists: Aguirre, Daniel – Alonso, José – Damsky Barbosa, Jesús – Rossi, Raúl – Zabal, Carlos.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...

TAVR in Young Low-Risk Patients

Transcatheter aortic valve replacement (TAVR) has established itself as an effective strategy for the treatment of severe aortic stenosis across different risk groups. While previous...

TAVR and Atrial Fibrillation: What Anticoagulants Should We Use?

The prevalence of atrial fibrillation (AF) in TAVR patients ranges from 15 to 30%, depending on series. This arrhythmia has been associated to higher...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...